(Q39516469)

12 September 2017

Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more (English)

1 reference

12 September 2017

1 reference

3

Charles G Drake

1 reference

12 September 2017

Meghan E Turnis

1

1 reference

PMCID

3494635

12 September 2017

Alan J Korman

series ordinal

2

1 reference

PMCID

3494635

12 September 2017

Dario A A Vignali

series ordinal

4

1 reference

12 September 2017

1 October 2012

1 reference

12 September 2017

1 reference

12 September 2017

1

1 reference

12 September 2017

7

1 reference

12 September 2017

1172-1174

1 reference

Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494635

Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494635

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494635

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494635

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494635

PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494635

Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494635

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494635

Role of LAG-3 in regulatory T cells.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494635

Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223)

12 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23170269

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/ONCI.20593

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

PMCID

3494635